Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware
Positron Corporation (OTC: POSC), a molecular imaging technology leader, has announced two strategic corporate developments. The company has established a new corporate headquarters in the Buffalo-Niagara Falls region under a long-term lease, which will serve as their corporate operations hub, product showroom, and testing center.
Additionally, Positron's Board of Directors has approved the company's redomiciling from Texas to Delaware. This move aims to enhance corporate governance and legal framework as the company prepares to file a Form 10 registration statement with the SEC to become a fully reporting public company.
Positron Corporation (OTC: POSC), azienda leader nelle tecnologie di imaging molecolare, ha annunciato due sviluppi strategici. Ha istituito una nuova sede aziendale nella regione di Buffalo-Niagara Falls con un contratto di locazione a lungo termine: la struttura funger脿 da centro operativo, showroom dei prodotti e centro di collaudo.
Inoltre, il Consiglio di Amministrazione di Positron ha approvato il trasferimento della sede legale dal Texas al Delaware. Questa operazione mira a rafforzare la governance societaria e il quadro giuridico mentre la societ脿 si prepara a presentare una dichiarazione di registrazione Form 10 alla SEC per diventare una societ脿 pubblica completamente soggetta agli obblighi di rendicontazione.
Positron Corporation (OTC: POSC), l铆der en tecnolog铆a de imagen molecular, ha anunciado dos desarrollos corporativos estrat茅gicos. La compa帽铆a ha establecido una nueva sede corporativa en la regi贸n de Buffalo-Niagara Falls bajo un contrato de arrendamiento a largo plazo, que servir谩 como centro de operaciones, sala de exposici贸n de productos y centro de pruebas.
Adem谩s, la Junta Directiva de Positron aprob贸 el traslado de su domicilio fiscal de Texas a Delaware. Esta medida busca mejorar la gobernanza corporativa y el marco legal mientras la compa帽铆a se prepara para presentar una declaraci贸n de registro Form 10 ante la SEC para convertirse en una empresa p煤blica que presenta informes completos.
Positron Corporation (OTC: POSC)電� 攵勳瀽 鞓侅儊 旮办垹 攵勳暭鞚� 靹犽弰 旮办梾鞙茧靹� 霊� 臧�歆� 鞝勲灥鞝� 氩曥澑 臧滊皽鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 鞛リ赴 鞛勲寑 瓿勳暯鞙茧 氩勴寯搿�-雮橃澊鞎勱皜霛� 韽彫 歆�鞐棎 靸堧鞖� 氤胳偓 靷鞁れ潉 靹る頄堨溂氅�, 鞚搓吵鞚� 氤胳偓 鞖挫榿 項堧笇鞚挫瀽 鞝滍拡 靽茧８ 氚� 韰岇姢韸� 靹柬劙搿� 頇滌毄霅� 鞓堨爼鞛呺媹雼�.
霕愴暅 韽韸鸽 鞚挫偓須岆姅 須岇偓鞚� 氩曥爜 氤胳偓毳� 韰嶌偓鞀れ棎靹� 雿鸽澕鞗柎搿� 鞚挫爠頃橂姅 瓴冹潉 鞀轨澑頄堨姷雼堧嫟. 鞚� 臁办箻電� 須岇偓臧� SEC鞐� Form 10 霌彪靹�毳� 鞝滌稖頃� 鞕勳爠 瓿奠嫓 鞚橂毳� 臧�歆�電� 靸侅灔靷皜 霅橁赴 鞙勴暅 欷�牍� 瓿检爼鞐愳劀 旮办梾 瓯半矂雱岇姢鞕� 氩曥爜 韹�鞚� 臧曧檾頃橂牑電� 氇╈爜鞛呺媹雼�.
Positron Corporation (OTC: POSC), leader en technologies d'imagerie mol茅culaire, a annonc茅 deux 茅volutions strat茅giques. La soci茅t茅 a 茅tabli un nouveau si猫ge social dans la r茅gion de Buffalo鈥慛iagara Falls sous bail de longue dur茅e, qui servira de centre op茅rationnel, de showroom produit et de centre d'essais.
Par ailleurs, le conseil d'administration de Positron a approuv茅 le d茅m茅nagement du si猫ge l茅gal du Texas vers le Delaware. Cette mesure vise 脿 renforcer la gouvernance d'entreprise et le cadre juridique alors que la soci茅t茅 se pr茅pare 脿 d茅poser une d茅claration d'enregistrement Form 10 aupr猫s de la SEC pour devenir une soci茅t茅 cot茅e pleinement assujettie aux obligations de reporting.
Positron Corporation (OTC: POSC), ein f眉hrendes Unternehmen im Bereich molekularer Bildgebungstechnologie, hat zwei strategische Unternehmensschritte angek眉ndigt. Das Unternehmen hat in der Region Buffalo鈥慛iagara Falls einen neuen Firmensitz unter einem langfristigen Mietvertrag eingerichtet, der als Betriebszentrale, Produktausstellungsraum und Testzentrum dienen wird.
Zudem hat der Vorstand von Positron die Verlegung des rechtlichen Sitzes von Texas nach Delaware genehmigt. Dieser Schritt zielt darauf ab, die Unternehmensf眉hrung und den rechtlichen Rahmen zu st盲rken, w盲hrend sich das Unternehmen auf die Einreichung einer Form 10-Registrierungserkl盲rung bei der SEC vorbereitet, um ein vollst盲ndig berichtspflichtiges b枚rsennotiertes Unternehmen zu werden.
- New headquarters expansion supports accelerated growth initiatives and operational capabilities
- Strategic move to Delaware enhances corporate governance structure
- Plans to become a fully reporting public company via Form 10 registration
- New facility includes product showroom and testing center for enhanced customer engagement
- Long-term lease commitment creates fixed financial obligations
North Tonawanda, NY, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (鈥淧ositron鈥� or the 鈥淐ompany鈥�) (OTC: POSC), a leader in molecular imaging technology and services, today announced that the Company had established a new corporate headquarters in the Buffalo-Niagara Falls region, and that its Board of Directors has approved the redomiciling of the Company from Texas to Delaware.
Signed under a long-term lease, the new headquarters will house corporate operations and serve as a product showroom and testing center. This expanded space is also expected to support Positron鈥檚 accelerated growth initiatives, enhance customer engagement, and provide new operational capabilities 鈥� enabling faster scaling of the Company鈥檚 PET-CT imaging solutions nationwide.
Further supporting the Company鈥檚 growth strategy, Positron鈥檚 redomiciling to the State of Delaware is aimed at enhancing the Company鈥檚 corporate governance and legal framework as it prepares to file a Form 10 registration statement with the U.S. Securities and Exchange Commission to become a fully reporting public company.
鈥淭hese steps forward mark an exciting new chapter in Positron鈥檚 evolution,鈥� said Positron President Adel Abdullah. 鈥淥ur strengthened corporate structure and expanded facility supports our growth and reinforces our ability to advance our strategic goals and deliver greater long term value to our customers and shareholders.鈥�
About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells聽 state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America.
Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron鈥檚 innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost effective medicine.
Positron's Attrius庐 PET and NeuSight PET-CT imaging systems and distinct market position are substantial advantages unique to Positron that will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device in the Affinity PET-CT 4D 64-Slice. Positron鈥檚 PET-CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron鈥檚 PET-CT systems will also enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine.
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co. a subsidiary of Neusoft Medical Systems.聽聽
Please visit the Company鈥檚 website at:
Forward-Looking Statements
听听听听听听听听听听听听听听听听听听听听听听听听听听听听听
This press release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Positron Corporation, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results even if new information becomes available in the future.
FOR FURTHER INFORMATION, please visit the company鈥檚 website at , or contact:
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
FAQ
Where is Positron Corporation's new headquarters located?
Why is Positron Corporation moving from Texas to Delaware?
What is the purpose of Positron's Form 10 registration with the SEC?
How will Positron's new headquarters benefit its operations?
What are the main features of Positron's new corporate facility?
